hydroxyindoleacetic acid has been researched along with talipexole in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koga, I; Nishikawa, T; Tanaka, M; Tsuda, A; Uchida, Y; Yamada, S | 1 |
| Hornykiewicz, O; Kobinger, W; Pichler, L; Pifl, C | 1 |
| Cooke, LW; Davis, MD; Heffner, TG | 1 |
3 other study(ies) available for hydroxyindoleacetic acid and talipexole
| Article | Year |
|---|---|
Chronic treatment with talipexole dihydrochloride on abnormal involuntary movement in humans.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Azepines; Dopamine Agents; Dystonia; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Middle Aged; Movement Disorders | 1990 |
The dopamine autoreceptor agonist, B-HT 920, preferentially reduces brain dopamine release in vivo: biochemical indices of brain dopamine, noradrenaline and serotonin in ventriculocisternal perfusates in the cat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic alpha-Agonists; Animals; Azepines; Brain; Cats; Cerebral Ventricles; Cisterna Magna; Dioxanes; Dopamine; Dopamine Agents; Female; Haloperidol; Homovanillic Acid; Hydroxyindoleacetic Acid; Idazoxan; Male; Norepinephrine; Serotonin | 1988 |
Dopamine agonist-induced inhibition of neurotransmitter release from the awake squirrel monkey putamen as measured by microdialysis.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Azepines; Consciousness; Dopamine; Dopamine Agonists; Hydroxyindoleacetic Acid; Longitudinal Studies; Male; Microdialysis; Neurotransmitter Agents; Putamen; Pyridines; Quinpirole; Receptors, Dopamine D2; Saimiri; Tetrodotoxin | 1997 |